1. HIGH EFFICACY AND SAFETY OF VTD AS AN INDUCTION PROTOCOL IN NEWLY DIAGNOSED MM PATIENTS ELIGIBLE FOR HDT/AUTOSCT – A REPORT OF POLISH MULTIPLE MYELOMA STUDY GROUP. (June 2017) Authors: Hus, I.; Manko, J.; Jawniak, D.; Jurczyszyn, A.; Usnarska‐Zubkiewicz, L.; Sawicki, M.; Charlinski, G.; Razny, M.; Rodzaj, M.; Waszczuk‐Gajda, A.; Drozd‐Sokolowska, J.; Galazka, A.; Swiderska, A.; Poglodek, B.; Pluta, A.; Druzd‐Sitek, A.; Grzasko, N.; Kopinska, A.; Pasternak, A.; Blonska, D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimal use of pegfilgrastim (a long-acting granulocyte-colony stimulating factor [G-CSF]) to manage chemotherapy-induced febrile neutropenia (FN) in haematological malignancies: consensus guidance recommendations. (February 2017) Authors: Aapro, M.; Boccia, R.; Choquet, S.; Hus, I.; Link, H.; Sliwa, T. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P1221: DIFFUSE LARGE B-CELL LYMPHOMA RICHTER SYNDROME IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES IN POLISH ADULT LEUKEMIA STUDY GROUP. (23rd June 2022) Authors: Sośnia, O.; Danecki, M.; Wąsik-Szczepanek, E.; Tryc-Szponder, J.; Iskierka-Jażdżewska, E.; Majeranowski, A.; Pruszczyk, K.; Krzemień, H.; Bołkun, L.; Paszkiewicz-Kozik, E.; Drozd-Sokołowska, J.; Kwiatkowski, J.; Wiśniewska-Organek, D.; Budziszewska, B.; Jamroziak, K.; Hus, I.; Lech-Marańda, E.; P... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS. (23rd June 2022) Authors: Zaleska, J.; Kwaśnik, P.; Paziewska, M.; Purkot, J.; Szabelak, A.; Jurek, M.; Masny, N.; Dziatkiewicz, I.; Własiuk, P.; Skórka, K.; Stasiak, G.; Pronobis-Szczylik, B.; Piebiak, A.; Szymczyk, A.; Jarosz-Chudzik, K.; Bołkun, L.; Kozłowska, K.; Piszcz, J.; Subocz, E.; Hałka, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P677: CLINICAL EFFICACY AND TOLERABILITY OF VENETOCLAX PLUS RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA – REAL WORLD ANALYSIS OF POLISH ADULT LEUKEMIA STUDY GROUP. (23rd June 2022) Authors: Soboń, A.; Drozd-Sokołowska, J.; Paszkiewicz-Kozik, E.; Popławska, L.; Morawska, M.; Tryc-Szponder, J.; Bołkun, L.; Rybka, J.; Pruszczyk, K.; Juda, A.; Majeranowski, A.; Iskierka-Jażdżewska, E.; Steckiewicz, P.; Wdowiak, K.; Budziszewska, B.; Jamroziak, K.; Hus, I.; Lech-Marańda, E.; Puła, B. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P692: IMMUNE FACTORS MAINTAINING TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF IMATINIB. (23rd June 2022) Authors: Kwaśnik, P.; Zaleska, J.; Link-Lenczowska, D.; Zawada, M.; Ochrem, B.; Bober, G.; Wasilewska, E.; Mędraś, E.; Hus, I.; Szarejko, M.; Prejzner, W.; Grzybowska-Izydorczyk, O.; Klonowska-Szymczyk, A.; Sacha, T.; Giannopoulos, K. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗